Healthy adults
Conditions
Interventions
None listed
Sponsors
KAGOME CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (PICOS) Participant: Healthy adults without illness (excluding pregnant women [including those planning to become pregnant] and lactating women) Intervention: Oral intake of test food containing Levilactobacillus brevis KB290 (regardless of the form and amount of intake) Comparison: Oral intake of test food without Levilactobacillus brevis KB290, or no intervention Outcome measurement: Bowel movement frequency as primary outcome. The number of Lactobacillus group and Bifidobacterium genus in stool sample, concentration of organic acids (total organic acid, acetic acid, propionic acid) in stool sample, and feeling after defecation as secondary outcomes. Study design: Randomized controlled parallel trials (RCT-P), randomized controlled crossover trials (RCT-C), quasi-randomized controlled parallel trials (qRCT-P), quasirandomized controlled crossover trials (qRCT-C), non-randomized controlled parallel trials (nonRCT-P), non-randomized controlled crossover trials (nonRCT-C), and non-randomized controlled trials (Language) Eligibility is not restricted by language.
Exclusion criteria
Exclusion criteria: Exclude proceedings and unpublished studies which don't give us enough research details, and other gray documents that are difficult to verify.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We will evaluate the effect of Levilactobacillus brevis KB290 intake on bowel movement frequency. | — |
Secondary
| Measure | Time frame |
|---|---|
| We will evaluate of the effects of Levilactobacillus brevis KB290 intake on the number of Lactobacillus group and Bifidobacterium genus in stool sample, concentration of organic acids (total organic acid, acetic acid, propionic acid) in stool sample, and feeling after defecation. | — |
Countries
Japan
Contacts
Public ContactChinatsu Arakawa
KAGOME CO., LTD. Diet & Well-being Research Institute
Outcome results
None listed